RxDoctor Payments Data

Nataliya Biskup

Plastic and Reconstructive Surgery · Hutchinson, KSNPI 1225353014

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 30.0% of the total. Reporting peaked in 2023 at $502 and has fallen 59.8% since, to $202 in 2025.

$2,209in general payments, 2019–2025

Across 98 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$664
  • AbbVie$372
  • TELA Bio, Inc.$298
  • Galderma Laboratories, L.p.$234
  • Sientra, Inc.$156
  • Vertex$79
  • plus $406 from 12 others
$128,788in research payments, 2019–2025

Across 5 payments — averaging $25,758 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$129K

What the payments were for

  • Food & beverage$2,209100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,209 in reported general payments places this provider in the 55th percentile of 35 plastic and reconstructive surgery providers in Kansas.

See all plastic and reconstructive surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$59,580
Medicare patients
110
Services billed
230

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$307
Cephalexin39$258
Ondansetron Hcl23$82
Ibuprofen23$81
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$49

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Hutchinson

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →